These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38244094)

  • 1. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review.
    Tayeh GA; Alkassis M; De La Taille A; Vordos D; Champy CM; Pelegrin T; Ingels A
    World J Urol; 2024 Jan; 42(1):51. PubMed ID: 38244094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma.
    Dr Hall B; Abel EJ
    Urol Clin North Am; 2020 Aug; 47(3):379-388. PubMed ID: 32600539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.
    Ouzaid I; Capitanio U; Staehler M; Wood CG; Leibovich BC; Ljungberg B; Van Poppel H; Bensalah K;
    Eur Urol Oncol; 2019 Mar; 2(2):141-149. PubMed ID: 31017089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.
    Zarba M; Fujiwara R; Yuasa T; Koga F; Heng DYC; Takemura K
    Expert Rev Anticancer Ther; 2024 Aug; 24(8):693-703. PubMed ID: 38813778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metastasis-directed treatment in kidney cancer.
    Psutka SP; Master VA
    Cancer; 2018 Sep; 124(18):3641-3655. PubMed ID: 29689599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metastasectomy in advanced renal cell carcinoma.
    Apollonio G; Raimondi A; Verzoni E; Claps M; Sepe P; Pagani F; Ratta R; Montorsi F; De Braud FGM; Procopio G
    Expert Rev Anticancer Ther; 2019 Jul; 19(7):603-611. PubMed ID: 31159619
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastasectomy in patients with renal cell carcinoma: when and how?
    Omid S; Abufaraj M; Remzi M
    Curr Opin Urol; 2020 Jul; 30(4):602-609. PubMed ID: 32464043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
    You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors].
    Firek P; Richter S; Jaekel J; Brehmer B; Heidenreich A
    Urologe A; 2012 Mar; 51(3):398-402. PubMed ID: 22113553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.
    Lyon TD; Thompson RH; Shah PH; Lohse CM; Boorjian SA; Costello BA; Cheville JC; Leibovich BC
    J Urol; 2020 Feb; 203(2):275-282. PubMed ID: 31393812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Bakouny Z; El Zarif T; Dudani S; Connor Wells J; Gan CL; Donskov F; Shapiro J; Davis ID; Parnis F; Ravi P; Steinharter JA; Agarwal N; Alva A; Wood L; Kapoor A; Ruiz Morales JM; Kollmannsberger C; Beuselinck B; Xie W; Heng DYC; Choueiri TK
    Eur Urol; 2023 Feb; 83(2):145-151. PubMed ID: 36272943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.
    Stenman M; Sinclair G; Paavola P; Wersäll P; Harmenberg U; Lindskog M
    Radiother Oncol; 2018 Jun; 127(3):501-506. PubMed ID: 29754859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    Kim DY; Karam JA; Wood CG
    World J Urol; 2014 Jun; 32(3):631-42. PubMed ID: 24744223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zaid HB; Parker WP; Safdar NS; Gershman B; Erwin PJ; Murad MH; Boorjian SA; Costello BA; Thompson RH; Leibovich BC
    J Urol; 2017 Jan; 197(1):44-49. PubMed ID: 27473875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.
    Hsiang WR; Kenney PA; Leapman MS
    Curr Oncol Rep; 2020 Mar; 22(4):35. PubMed ID: 32170461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and novel insights into the role of metastasectomy in the era of immunotherapy.
    Liatsou E; Tsilimigras DI; Malandrakis P; Gavriatopoulou M; Ntanasis-Stathopoulos I
    Expert Rev Anticancer Ther; 2023 Jan; 23(1):57-66. PubMed ID: 36527305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
    Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of metastasectomy in patients with metastatic renal cell carcinoma].
    Miyata H; Shinohara N; Murahashi N; Tsuchiya K; Miyajima N; Maruyama S; Abe T; Kaga K; Hirano S; Nonomura K
    Hinyokika Kiyo; 2015 Feb; 61(2):49-54. PubMed ID: 25812593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.
    Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M
    Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
    Bhindi B; Abel EJ; Albiges L; Bensalah K; Boorjian SA; Daneshmand S; Karam JA; Mason RJ; Powles T; Bex A
    Eur Urol; 2019 Jan; 75(1):111-128. PubMed ID: 30467042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.